Overview

Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Africa and Asia. The aim of this study is to evaluate the efficacy of home treatment of joint bleeds (haemarthrosis) with NovoSeven® (activated recombinant human factor VII) in patients with haemophilia A and B patients with inhibitors.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Factor VIII